Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis

Published:2020-12-07 Issue:1 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Lee Bei Shi¹,Hards Kiel²³,Engelhart Curtis A⁴,Hasenoehrl Erik J⁵^ORCID,Kalia Nitin P⁶⁷,Mackenzie Jared S⁸^ORCID,Sviriaeva Ekaterina¹,Chong Shi Min Sherilyn¹⁹,Manimekalai Malathy Sony S¹,Koh Vanessa H¹⁰¹¹,Chan John¹²,Xu Jiayong¹²,Alonso Sylvie¹⁰¹¹,Miller Marvin J¹³,Steyn Adrie J C⁸¹⁴,Grüber Gerhard¹,Schnappinger Dirk⁴,Berney Michael⁵,Cook Gregory M²³,Moraski Garrett C¹⁵,Pethe Kevin¹⁶^ORCID

Affiliation:

1. School of Biological Sciences Nanyang Technological University Singapore Singapore

2. Department of Microbiology and Immunology School of Biomedical Sciences University of Otago Dunedin New Zealand

3. Maurice Wilkins Centre for Molecular Biodiscovery University of Auckland Auckland New Zealand

4. Department of Microbiology and Immunology Weill Cornell Medical College New York NY USA

5. Department of Microbiology and Immunology Albert Einstein College of Medicine Bronx NY USA

6. Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore

7. Ramalingaswami Fellow Clinical Microbiology Division CSIR‐IIIM Jammu and Kashmir India

8. Africa Health Research Institute Nelson R. Mandela School of Medicine University of KwaZulu‐Natal Durban South Africa

9. Nanyang Institute of Technology in Health and Medicine Interdisciplinary Graduate School Nanyang Technological University Singapore Singapore

10. Department of Microbiology Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

11. Infectious Disease Programme Department of Microbiology and Immunology National University of Singapore Singapore Singapore

12. Department of Medicine Albert Einstein College of Medicine Bronx NY USA

13. Department of Chemistry and Biochemistry University of Notre Dame Notre Dame IN USA

14. Department of Microbiology University of Alabama Birmingham AL USA

15. Department of Chemistry and Biochemistry Montana State University Bozeman MT USA

Funder

Royal Society of New Zealand

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013207

Reference72 articles.

1. Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

2. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

3. Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis

4. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development

5. Whole-Transcriptome Sequencing for High-Resolution Transcriptomic Analysis in Mycobacterium tuberculosis

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Acyl phenothiazines as mycobacterial ATP synthase inhibitors: Rational design, synthesis and in vitro evaluation against drug sensitive, RR and MDR-TB;Bioorganic Chemistry;2024-10

2. Crystal structure, DFT calculation, molecular docking, in vitro biological activity evaluation and in silico drug-likeness prediction of N-((1H-indol-3-yl)methyl)-4-(piperidin-1-yl)aniline;Journal of Molecular Structure;2024-09

3. Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase;Journal of Chemical Information and Modeling;2024-06-14

4. New synergistic benzoquinone scaffolds as inhibitors of mycobacterial cytochrome bc1 complex to treat multi-drug resistant tuberculosis;European Journal of Medicinal Chemistry;2024-06

5. Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis;Antimicrobial Agents and Chemotherapy;2024-05